PPXP Insider Trading Activity and SEC Form 4 Filings
PPXP insider trading summary
No open-market insider purchases or sales of Pipex Pharmaceuticals, Inc. (PPXP) have been reported on SEC Form 4 in the past 12 months.
Latest PPXP insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Apr 17, 2007 | Steve H Kanzer | Chief Executive Officer | Buy | $11K (5,000 @ $2.10) |
| Apr 17, 2007 | Steve H Kanzer | Chief Executive Officer | Buy | $5K (2,500 @ $2.05) |
| Apr 17, 2007 | Steve H Kanzer | Chief Executive Officer | Buy | $50K (25,000 @ $2.00) |
| Apr 17, 2007 | Steve H Kanzer | Chief Executive Officer | Buy | $28K (13,500 @ $2.09) |
| Apr 17, 2007 | Steve H Kanzer | Chief Executive Officer | Buy | $40K (20,000 @ $1.99) |
| Apr 16, 2007 | Steve H Kanzer | Chief Executive Officer | Buy | $19K (10,000 @ $1.86) |
| Apr 16, 2007 | Steve H Kanzer | Chief Executive Officer | Buy | $63K (32,500 @ $1.95) |
| Apr 16, 2007 | Steve H Kanzer | Chief Executive Officer | Buy | $20K (10,000 @ $1.99) |
| Apr 16, 2007 | Steve H Kanzer | Chief Executive Officer | Buy | $75K (41,000 @ $1.84) |
| Apr 16, 2007 | Steve H Kanzer | Chief Executive Officer | Buy | $17K (8,500 @ $2.05) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.